Literature DB >> 20495938

Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations.

Violetta D Kapsimali1, Meletios A Kanakis, George A Vaiopoulos, Phaedon G Kaklamanis.   

Abstract

Behçet's disease (BD) is a chronic multisystemic inflammatory disorder of unknown origin consisting of oral aphthous ulcers, ocular symptoms, skin lesions, and genital ulcerations. It has many features in common with systemic vasculitides and is more prevalent in countries along the ancient Silk route. Immune-mediated mechanisms play a major role in the pathogenesis of the disease, and inflammatory mediators are also involved. BD is not considered to be an autoimmune disorder, and the character of the disease needs to be clarified. Immunological aberrations in BD have been extensively studied by many investigators; genetic factors have been related to disease susceptibility, but their exact role in the development of disease is uncertain. Environmental factors such as infectious agents have also been implicated in the etiology of BD. However, the etiopathogenesis of the disease remains to be elucidated. Factors involved in the immunopathogenesis of BD with emphasis on the role of immunological aberrations are analyzed in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495938     DOI: 10.1007/s10067-010-1491-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  57 in total

Review 1.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

Review 2.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

3.  Vascular endothelial function and plasma homocysteine levels in Behcet's disease.

Authors:  Ramazan Ozdemir; Irfan Barutcu; Alpay T Sezgin; Nusret Acikgoz; Necip Ermis; Ali Metin Esen; Ergun Topal; Emrah Bariskaner; Ibrahim Ozerol
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

4.  Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.

Authors:  Yeşim Ozkan; Sevgi Yardim-Akaydin; Aylin Sepici; Başak Engin; Vesile Sepici; Bolkan Simşek
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

Review 5.  An update on Behçet's disease.

Authors:  A Kalayciyan; Cc Zouboulis
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-01       Impact factor: 6.166

6.  Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome.

Authors:  Felix Mor; Abraham Weinberger; Irun R Cohen
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

7.  Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behçet's disease.

Authors:  I Krause; Y Monselise; G Milo; A Weinberger
Journal:  Clin Exp Rheumatol       Date:  2002 Jul-Aug       Impact factor: 4.473

8.  Adamantiades-Behçet's disease, deep venous thrombosis and anticardiolipin antibodies: report of two cases.

Authors:  L Kandolf-Sekulovic; M D Pavlovic; B Glisic; M Petronijevic; G Ristic; Z Mijuskovic; R D Zecevic; D Stefanovic
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-07       Impact factor: 6.166

9.  Neutrophil activation in Behçet's disease.

Authors:  E Eksioglu-Demiralp; H Direskeneli; A Kibaroglu; S Yavuz; T Ergun; T Akoglu
Journal:  Clin Exp Rheumatol       Date:  2001 Sep-Oct       Impact factor: 4.473

10.  Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behçet's disease.

Authors:  E Birtas-Atesoglu; N Inanc; S Yavuz; T Ergun; H Direskeneli
Journal:  Clin Exp Rheumatol       Date:  2008 Jul-Aug       Impact factor: 4.473

View more
  25 in total

Review 1.  Evaluation of current therapeutic strategies in Behçet's disease.

Authors:  Iliana Alexoudi; Violetta Kapsimali; Aristides Vaiopoulos; Meletios Kanakis; George Vaiopoulos
Journal:  Clin Rheumatol       Date:  2010-09-15       Impact factor: 2.980

2.  The role of IL-23/IL-17 axis in the etiopathogenesis of Behçet's disease.

Authors:  Rui-Xue Leng; Gui-Mei Chen; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2010-07-13       Impact factor: 2.980

3.  Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.

Authors:  Murat Yuksel; Abdulkadir Yildiz; Mustafa Oylumlu; Fatih Mehmet Turkcu; Mehmet Zihni Bilik; Aysun Ekinci; Bilal Elbey; Ebru Tekbas; Sait Alan
Journal:  Clin Rheumatol       Date:  2015-03-07       Impact factor: 2.980

4.  Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behçet's disease susceptibility.

Authors:  Joana M Xavier; Tiago Krug; Fereydoun Davatchi; Farhad Shahram; Benedita V Fonseca; Gorete Jesus; Filipe Barcelos; Joana Vedes; Manuel Salgado; Bahar Sadeghi Abdollahi; Abdolhadi Nadji; Maria Francisca Moraes-Fontes; Niloofar Mojarad Shafiee; Fahmida Ghaderibarmi; José Vaz Patto; Jorge Crespo; Sofia A Oliveira
Journal:  J Mol Med (Berl)       Date:  2013-04-27       Impact factor: 4.599

Review 5.  Neonatal Behçet's disease without maternal history.

Authors:  Yung-Sen Chang; Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rheumatol       Date:  2011-08-26       Impact factor: 2.980

6.  Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.

Authors:  Özlem Aydinoglu-Candan; Bilge Araz-Erşan; Ahmet Gul; Selim Badur; Ilknur Tugal-Tutkun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-12       Impact factor: 3.117

Review 7.  Differential diagnosis and management of Behçet syndrome.

Authors:  Nicola L Ambrose; Dorian O Haskard
Journal:  Nat Rev Rheumatol       Date:  2012-09-25       Impact factor: 20.543

8.  Genital aphthosis in Behçet's disease: is it associated with less eye involvement?

Authors:  Seyedeh Tahereh Faezi; Cheyda Chams-Davatchi; S Zahra Ghodsi; Farhad Shahram; Abdolhadi Nadji; Massoomeh Akhlaghi; Kamran Moradi; Pedram Paragomi; Golnaz Ghazizadeh Esslami; Bahar Sadeghi Abdollahi; Farimah Ashofteh; Fereydoun Davatchi
Journal:  Rheumatol Int       Date:  2014-04-12       Impact factor: 2.631

9.  Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.

Authors:  Fatmazohra Djaballah-Ider; Zineb Djeraba; Mourad Chemli; Nadjiba Dammene-Debbihe; Doulkifly Lounis; Houda Belguendouz; Yanis Medour; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-29       Impact factor: 4.473

Review 10.  Current and future treatments for Behçet's uveitis: road to remission.

Authors:  Marina Mesquida; Blanca Molins; Victor Llorenç; María Victoria Hernández; Gerard Espinosa; Andrew D Dick; Alfredo Adán
Journal:  Int Ophthalmol       Date:  2013-06-01       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.